JERSEY CITY, NJ / ACCESSWIRE / May 20, 2015 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT:AXN) ("Aoxing Pharma" or the "Company"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals will be hosting an investor luncheon from noon to 1:30 p.m. in New York, N.Y., on May 27th, 2015, and in Boston, Mass., on May 28th, 2015, to discuss continued growth and success within the pharmaceutical industry.
The luncheons will provide an opportunity to hear from and meet members of the Aoxing Pharma's management team. The luncheons will feature a presentation about their line of products and discuss how it will better position Aoxing for immediate and long- term growth and enhanced profitability.
NEW YORK CITY
LUNCHEON AGENDA
Registration: 11:30 a.m. to noon at the Plymouth Room 9th Floor
Executive Presentations and Question &Answer Session: Noon to 1:30 p.m., Plymouth Room
9th Floor
LOCATION
Venue:Westin Times Square
Address: Westin New York Times Square 270 W 43rd St, New York, NY 10036 Plymouth Room 9th Floor
BOSTON
LUNCHEON AGENDA
Registration: 11:30 a.m. to Noon, at The Madison Room
Executive Presentations and Question & Answer Session: Noon to 1:30 p.m., The Madison Room
LOCATION
Venue: The Langham Hotel
Address: 250 Franklin St, Boston, MA 02110
About Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc. is a US incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. Headquartered in Shijiazhuang City, outside Beijing, Aoxing Pharma has the largest and most advanced manufacturing facility in China for highly regulated narcotic medicines. Its facility is one of the few GMP facilities licensed for the manufacture of narcotic medicines by the China State Food and Drug Administration (CFDA). For more information, please visit: www.aoxingpharma.com.
CONTACT:
Aoxing Pharmaceutical Company:
646-367-1747
investor.relations@aoxingpharma.com
SOURCE: Aoxing Pharmaceutical Company, Inc.
